CrushSCI.com
90.4Average days
83Median days
26Fastest days
178Longest days
232025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

56 days

Metabolism of new drug modalities research advances – 2025 year in review

Authors
Bin Ma; Lionel Cheruzel; Sungjoon Cho; Simon Hauri; Xiuli Li; Joyce Liu; Karoline Rehm; Herana Kamal Seneviratne; Hyeonglim Seo; Rachel Liuqing Shi; Lloyd Wei Tat Tang; Pengcheng Wang; Yue-Ting Wang; Caroline Wei; Guo Zhong; S. Cyrus KhojastehShow moreShow less
Affiliations
1. Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc; 2. Roche Pharma Research and Early Development, Pharmaceutical Sciences; 3. Department of Pharmaceutical Sciences, China Innovation Center of Roche; 4. Department of Chemistry and Biochemistry, University of Maryland; 5. Department of Biochemical and Cellular Pharmacology, Genentech, Inc; 6. Pharmacokinetics, Dynamics, and Metabolism, Pfizer Inc; 7. Pharmacokinetic Sciences Biomedical Research; 8. Quantitative, Translational, & ADME Sciences (QTAS), AbbVie Inc; 9. Quantitative Clinical Pharmacology, Daiichi Sankyo Inc; 10. Pharmacokinetics and Drug Metabolism DepartmentShow moreShow less
Source PDF DOI Publisher page
79 days

Extracellular vesicles as xenobiotic-metabolizing enzyme carriers: a new paradigm for brain drug metabolism

Authors
Veena V Tom; Ann Mary Jose; Athira Sasidharan; Yogish Somayaji; Ronald FernandesShow moreShow less
Affiliations
1. Department of Allied Health Sciences, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS); 2. Department of Post Graduate Studies and Research in Biochemistry, St. Aloysius (Deemed to be University); 3. Department of Biochemistry and Biophysics, Texas A&M University; 4. Department of Pharmaceutical Chemistry, Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS)Show moreShow less
Source PDF DOI Publisher page
26 days

Cytochrome P450-derived arachidonic acid metabolites as emerging therapeutic targets in menopause-associated cardiac hypertrophy

Authors
Mostafa K. Abd El-Aziz; Ali H. Shalaby; Sara R. El-Mahrouk; Ayman O. S. El-KadiShow moreShow less
Affiliations
1. Faculty of Pharmacy and Pharmaceutical Sciences, University of AlbertaShow moreShow less
Source PDF DOI Publisher page
83 days

Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic review

Authors
Tahir Saleem; Muhammad Fawad Rasool; Hamid Saeed; Faleh AlqahtaniShow moreShow less
Affiliations
1. Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University; 2. University College of Pharmacy, Allama Iqbal Campus, University of the Punjab; 3. Department of Pharmacology and Toxicology, College of Pharmacy, King Saud UniversityShow moreShow less
Source PDF DOI Publisher page
113 days

A review on analytical perspectives for cyclophosphamide, its metabolites, and impurities

Authors
Harshal Ahirrao; Hemant Kumar Tatapudi; Kishore Raju VatsavaiShow moreShow less
Affiliations
1. Department of Pharmaceutical Quality Assurance, School of Pharmacy & Technology Management, SVKMs NMIMS; 2. Veranova LPShow moreShow less
Source PDF DOI Publisher page
77 days

Redox enzyme networks shaping cancer drug metabolism and therapeutic resistance

Authors
Başak Gökçe; Şeyma Rana KarakaşShow moreShow less
Affiliations
1. Department of Biochemistry, Faculty of Pharmacy, Suleyman Demirel University; 2. Faculty of Pharmacy, Suleyman Demirel UniversityShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.